Salud
La FDA no encontró violaciones en los sitios de prueba con respecto a la vacuna contra la enfermedad de Lyme de Pfizer
A U.S. health regulator found no violations at clinical centres run by Care Access for Pfizer and French partner Valneva in a trial of a
Más de 7 millones de estadounidenses han recibido vacunas COVID actualizadas
According to the US Department of Health and Human Services, more than 7 million Americans have received the updated COVID-19 vaccines, despite reports that some
India autoriza empresa de jarabe para la tos vinculada a muertes uzbecas
The northern Indian state of Uttar Pradesh has authorised the resumption of most of the production at a plant owned by Marion Biotech that made
El tribunal aprueba la reestructuración de Mallinckrodt y un recorte de $1 mil millones en el reembolso de opioides
Pharmaceutical company Mallinckrodt has received court approval for a bankruptcy plan that reduces by $1 billion the amount it owes to victims of the opioid
El fabricante de medicamentos GSK resuelve otra demanda en California por el medicamento para la acidez estomacal Zantac
GSK on Wednesday said it would confidentially settle another lawsuit in California alleging that its discontinued heartburn drug Zantac caused cancer, as the British drugmaker
Alnylam se niega a ampliar el uso de medicamentos para enfermedades cardíacas en EE. UU.
Alnylam Pharmaceuticals said it will not expand the use of its drug to treat a potentially fatal heart condition in the U.S. after the Food
El número de empleadores estadounidenses que pagan por medicamentos para bajar de peso podría casi duplicarse en 2024
The number of U.S. employers paying for obesity drugs, including Novo Nordisk’s Wegovy, which belongs to the GLP-1 class of drugs, could nearly double next
El fármaco para enfermedades de la piel AnaptysBio alcanza un importante objetivo de estudio en fase avanzada
AnaptysBio said its experimental drug to treat one of the rare skin diseases has achieved the primary endpoint of a late-stage study. The drug helped
Gates dona $40 millones para impulsar el acceso a vacunas de ARNm en África
The Bill & Melinda Gates Foundation will donate $40 million to a Belgian biotech company and two leading African vaccine manufacturers in a bid to
Bristol-Myers Squibb adquirirá Mirati por $5.800 millones
Bristol-Myers Squibb announced it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can